The head of Germany’s medicines cost-effectiveness watchdog was forced to resign because he was a vocal critic of the pharma …
Chancellor Angela Merkel’s coalition government has agreed to raise health insurance premiums by over half a percent in a further …

Major changes are afoot in Germany and the UK, the last two European countries with ‘free pricing’ of pharmaceuticals. Governments …
A Munich court has ruled GlaxoSmithKline’s combination patent for its asthma and COPD treatment Seretide is not valid. The Federal …
Pharma industry organisations have reacted angrily to new government plans in Germany which would enforce mandatory price reductions one year …
German Health Minister Philipp Rösler wants to break pharma’s ‘monopolistic hold’ over the country by introducing price limits on new …

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has said that registration and publication of all clinical trials …
UCB and Novartis have extended their partnership in Germany with a new licensing deal for the cardiovascular and diabetes drug …
GlaxoSmithKline has announced a price freeze on its drugs and vaccines in Germany for 2009. The freeze applies to drugs …
Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …
Bayer has called for more tax breaks to support research and development in Germany.The company has urged the German government …
Contract research organisation PRA International has opened a new office in Munich, its third base in Germany. Several major pharmaceutical …
Sanofi-Aventis and Bristol-Myers Squibb are feeling the heat from a Swiss drugs company which intends to market a generic version …
Astellas has announced streamlining and cutbacks to its operations across Europe, with operations in Germany losing staff in its saleforce …